Diabetologia

, Volume 37, Issue 2, pp 150–154 | Cite as

Thinness at birth and insulin resistance in adult life

  • D. I. W. Phillips
  • D. J. P. Barker
  • C. N. Hales
  • S. Hirst
  • C. Osmond
Article

Summary

Type 2 (non-insulin-dependent) diabetes mellitus may originate through impaired development in fetal life. Both insulin deficiency and resistance to the action of insulin are thought to be important in its pathogenesis. Although there is evidence that impaired fetal development may result in insulin deficiency, it is not known whether insulin resistance could also be a consequence of reduced early growth. Insulin resistance was therefore measured in 81 normoglycaemic subjects, and 22 subjects with impaired glucose tolerance, who were born in Preston, UK, between 1935 and 1943. Their birth measurements had been recorded in detail. Insulin resistance was measured by the insulin tolerance test which uses the rate of fall in blood glucose concentrations after intravenous injection of insulin as an index of insulin resistance. Men and women who were thin at birth, as measured by a low ponderal index, were more insulin resistant. The association was statistically significant (p = 0.01) and independent of duration of gestation, adult body mass index and waist to hip ratio and of confounding variables including social class at birth or currently. Thinness at birth and in adult life has opposing effects such that resistance fell with increasing ponderal index at birth but rose with increasing adult body mass index. It is concluded that insulin resistance is associated with impaired development in fetal life.

Key words

Type 2 (non-insulin-dependent) diabetes mellitus insulin resistance fetal growth metabolic programming 

References

  1. 1.
    Hales CN, Barker DJP, Clark PMS et al. (1991) Fetal and infant growth and impaired glucose tolerance at age 64 years. BMJ 303: 1019–1022PubMedCrossRefGoogle Scholar
  2. 2.
    Phipps K, Barker DJP, Hales CN, Fall CHD, Osmond C, Clark PMS (1993) Fetal growth and impaired glucose tolerance in men and women. Diabetologia 36: 225–228PubMedCrossRefGoogle Scholar
  3. 3.
    Robinson S, Walton RJ, Clark PM, Barker DJP, Hales CN, Osmond C (1992) The relation of fetal growth to plasma glucose in young men. Diabetologia 35: 444–446PubMedCrossRefGoogle Scholar
  4. 4.
    Athens M, Valdez R, Stern M (1993) Effect of birthweight on future development of “Syndrome X” in adult life. Diabetes 42 [Suppl 1]: 61A (Abstract)Google Scholar
  5. 5.
    Reaven GM, Bernstein R, Davis B, Olefsky JM (1976) Nonketotic diabetes mellitus: insulin deficiency or insulin resistance? Am J Med 60: 80–88PubMedCrossRefGoogle Scholar
  6. 6.
    Cahill GF (1988) Beta-cell deficiency, insulin resistance or both? New Engl J Med 318: 1268–1269PubMedCrossRefGoogle Scholar
  7. 7.
    Van Assche FA, Aerts L (1979) The fetal endocrine pancreas. Contrib Gynecol Obstet 5: 44–57PubMedGoogle Scholar
  8. 8.
    Economides DL, Proudler A, Nicolaides KH (1989) Plasma insulin in appropriate and small-for-gestational-age fetuses. Am J Obstet Gynecol 160: 1091–1094PubMedGoogle Scholar
  9. 9.
    Cook JTE, Levy JC, Page RCL, Shaw JAG, Hattersley AT, Turner RC (1993) Association of low birth weight with β-cell function in the adult first degree relatives of non-insulin dependent diabetic subjects. BMJ 306: 302–305PubMedCrossRefGoogle Scholar
  10. 10.
    Olefsky J, Reaven GM, Farquhar JW (1974) Effects of weight reduction on obesity: studies of lipid and carbohydrate metabolism in normal and hyperlipoproteinaemic subjects. J Clin Invest 53: 64–76PubMedCrossRefGoogle Scholar
  11. 11.
    Koivisto VA, Yki-Järvinen H, DeFronzo RA (1986) Physical training and insulin sensitivity. Diabetes Metab Rev 1: 445–481PubMedGoogle Scholar
  12. 12.
    Barker DJP, Hales CN, Fall CHD, Osmond C, Phipps K, Clark PMS (1993) Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia 36: 62–67PubMedCrossRefGoogle Scholar
  13. 13.
    Reaven GM (1988) Role of insulin resistance in human disease. Diabetes 37: 1595–1607PubMedCrossRefGoogle Scholar
  14. 14.
    Bonora E, Moghetti P, ZanCanaro C et al. (1989) Estimates of in vivo insulin action in man: comparison of insulin tolerance tests with euglycaemic and hyperglycaemic clamp studies. J Clin Endocrinol Metab 68: 374–378PubMedGoogle Scholar
  15. 15.
    Barker DJP, Bull AR, Osmond C, Simmonds SJ (1990) Fetal and placental size and risk of hypertension in adult life. BMJ 301: 259–262PubMedGoogle Scholar
  16. 16.
    Forster HV, Dempsey JA, Thompson J, Vidruk E, doPico GA (1972) Estimation of arterial PO2, PCO2, pH and lactate from arterialized venous blood. J Appl Phys 32: 134–137Google Scholar
  17. 17.
    Del Prato S, Ferrannini E, DeFronzo RA (1986) Evaluation of insulin sensitivity in man. In: Clarke WL, Larner J, Pohl SL (eds) Methods in diabetes research Vol 2: clinical methods. Wiley, New York, pp 39–43Google Scholar
  18. 18.
    Hirst S, Phillips DIW, Vines SK, Clark PMS, Hales CN (1993) Reproducibility of the short insulin tolerance test. Diabetic Med 10: 839–842PubMedCrossRefGoogle Scholar
  19. 19.
    Barker DJP, Godfrey KM, Osmond C, Bull A (1992) The relation of fetal length, ponderal index, and head circumference to blood pressure and the risk of hypertension in adult life. Paed Perinat Epidemiol 6: 35–44CrossRefGoogle Scholar
  20. 20.
    Akinmokum A, Selby PL, Ramaiya K, Alberti KGMM (1992) The short insulin tolerance test for determination of insulin sensitivity: a comparison with the euglycaemic clamp. Diabetic Med 9: 432–437Google Scholar
  21. 21.
    Stamler J, Rhomberg P, Schroenberger JA et al. (1975) Multivariate analysis of the relationship of seven variables to blood pressure: findings of the Chicago Heart Association detection project in industry. 1967–1972. J Chron Dis 28: 527–548PubMedCrossRefGoogle Scholar
  22. 22.
    Modan M, Halkin H, Almog S et al. (1985) Hyperinsulinaemia: a link between hypertension, obesity and glucose intolerance. J Clin Invest 75: 809–817PubMedCrossRefGoogle Scholar
  23. 23.
    Ferrannini E, Haffner SM, Mitchell BD, Stern MP (1991) Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 34: 416–422PubMedCrossRefGoogle Scholar
  24. 24.
    Yudkin J (1991) Hypertension and non-insulin dependent diabetes. BMJ 303: 730–731PubMedCrossRefGoogle Scholar
  25. 25.
    Law CM, Barker DJP, Bull AR, Osmond C (1991) Maternal and fetal influences on blood pressure. Arch Dis Child 66: 1291–1295PubMedCrossRefGoogle Scholar
  26. 26.
    Barker DJP, Osmond C, Simmonds SJ, Wield GA (1993) The relation of head circumference and thinness at birth to death from cardiovascular disease in adult life. BMJ 306: 422–426PubMedCrossRefGoogle Scholar
  27. 27.
    DeFronzo RA (1988) The triumvirate: β-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 37: 667–687PubMedGoogle Scholar
  28. 28.
    Lillioja S, Young AA, Culter CL et al. (1987) Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man. J Clin Invest 80: 415–424PubMedCrossRefGoogle Scholar
  29. 29.
    Bergman RN, Yang YJ, Hope ID, Ader M (1990) The role of the transcapillary insulin transport in the efficiency of insulin action: studies with glucose clamps and the minimal model. Horm Metab Res 24 [Suppl]: 49–56Google Scholar
  30. 30.
    Robinson SM, Wheeler T, Hayes MC, Barker DJP, Osmond C (1991) Fetal heart rate and intrauterine growth. Br J Obstet Gynaecol 98: 1223–1227PubMedGoogle Scholar
  31. 31.
    Hales CN, Barker DJP (1992) Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia 35: 595–601PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 1994

Authors and Affiliations

  • D. I. W. Phillips
    • 1
  • D. J. P. Barker
    • 2
  • C. N. Hales
    • 3
  • S. Hirst
    • 1
  • C. Osmond
    • 2
  1. 1.Metabolic Programming GroupUniversity of Southampton, Southampton General HospitalSouthamptonUK
  2. 2.MRC Environmental Epidemiology UnitUniversity of Southampton, Southampton General HospitalSouthamptonUK
  3. 3.Department of Clinical BiochemistryUniversity of Cambridge, Addenbrooke’s HospitalCambridgeUK

Personalised recommendations